European Urology

European Urology

Volume 50, issue 3, pages 395-634, September 2006

Viewing articles 11-20 of 55


topEditorials

Adherence to the Right Diagnostic Tools for Best Outcomes in Urethral Reconstructive Surgery

Guido Barbagli.

24 January 2006 | pages 424 - 425

Full Text Full-Text PDF (55 KB)

Free


The Metabolic Syndrome and Erectile Dysfunction: Multiple Vascular Risk Factors and Hypogonadism

Graham Jackson.

31 March 2006 | pages 426 - 427

Full Text Full-Text PDF (57 KB)

Free


topReviews

[Editorial Comments by G. Thalmann and by P. Karakiewicz]

Management of the Spectrum of Hormone Refractory Prostate Cancer

Noel W. Clarke.

2 June 2006 | pages 428 - 439

Abstract Full Text Full-Text PDF (182 KB)

[Editorial Comment by J. Irani]

  The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms

Jules H. Schagen van Leeuwen, Ramiro Castro, Michael Busse, Bart L.H. Bemelmans.

19 May 2006 | pages 440 - 453

Abstract Full Text Full-Text PDF (328 KB) Create Platinum Slide Series

  Serotonin and Premature Ejaculation: From Physiology to Patient Management Serotonin and Premature Ejaculation: From Physiology to Patient Management

François Giuliano, Pierre Clément.

19 June 2006 | pages 454 - 466

Abstract Full Text Full-Text PDF (349 KB) Create Platinum Slide Series

topSurgery in Motion

  Bulbar Urethroplasty with Dorsal Onlay Buccal Mucosal Graft and Fibrin Glue Bulbar Urethroplasty with Dorsal Onlay Buccal Mucosal Graft and Fibrin Glue

Guido Barbagli, Stefano De Stefani, Maria Chiara Sighinolfi, Filippo Annino, Salvatore Micali, Giampaolo Bianchi.

5 June 2006 | pages 467 - 474

Abstract Full Text Full-Text PDF (411 KB) Activate Visual Create Platinum Slide Series

topProstate Cancer

  Management and Survival of Screen-Detected Prostate Cancer Patients who Might Have Been Suitable for Active Surveillance Management and Survival of Screen-Detected Prostate Cancer Patients who Might Have Been Suitable for Active Surveillance

Stijn Roemeling, Monique J. Roobol, Renske Postma, Claartje Gosselaar, Theo H. van der Kwast, Chris H. Bangma, Fritz H. Schröder.

3 May 2006 | pages 475 - 482

Abstract Full Text Full-Text PDF (159 KB) Create Platinum Slide Series

Free


  Duration of Testosterone Suppression after a 9.45mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate Duration of Testosterone Suppression after a 9.45 mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate: A 12-Month Follow-up Study

Bill Pettersson, Eberhard Varenhorst, Anssi Petas, Jürgen Sandow.

27 March 2006 | pages 483 - 489

Abstract Full Text Full-Text PDF (176 KB) Create Platinum Slide Series

  Evaluation of Color Doppler in Guiding Prostate Biopsy after HIFU Ablation Evaluation of Color Doppler in Guiding Prostate Biopsy after HIFU Ablation

Olivier Rouvière, Florence Mège-Lechevallier, Jean-Yves Chapelon, Albert Gelet, Raymonde Bouvier, Florent Boutitie, Denis Lyonnet.

13 January 2006 | pages 490 - 497

Abstract Full Text Full-Text PDF (233 KB) Create Platinum Slide Series

  High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series

Jochen Walz, Markus Graefen, Felix K.-H. Chun, Andreas Erbersdobler, Alexander Haese, Thomas Steuber, Thorsten Schlomm, Hartwig Huland, Pierre I. Karakiewicz.

29 March 2006 | pages 498 - 505

Abstract Full Text Full-Text PDF (283 KB) Create Platinum Slide Series

Viewing articles 11-20 of 55


Listing options

Free Content

Top 10 cited